Sionna Therapeutics (SION) EPS (Basic) (2024 - 2026)
Quarterly results put EPS (Basic) at -$0.6 for Q1 2026, up 3.23% from a year ago — trailing twelve months through Mar 2026 was -$411.51 (up 84.87% YoY), and the annual figure for FY2025 was -$1.88, up 88.24%.
Sionna Therapeutics has reported EPS (Basic) over the past 3 years, most recently at -$0.6 for Q1 2026.
- EPS (Basic) reached -$0.6 in Q1 2026 per SION's latest filing, down from -$0.45 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.45 in Q4 2025 and bottomed at -$3840.0 in Q1 2024.
- Median EPS (Basic) over the past 3 years was -$3.18 (2024), compared with a mean of -$774.55.
- The largest annual shift saw EPS (Basic) skyrocketed 99.98% in 2025 before it rose 3.23% in 2026.
- Over 3 years, EPS (Basic) stood at -$3.18 in 2024, then soared by 85.85% to -$0.45 in 2025, then plummeted by 33.33% to -$0.6 in 2026.
- Business Quant data shows EPS (Basic) for SION at -$0.6 in Q1 2026, -$0.45 in Q4 2025, and -$0.46 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.06 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.99 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.55 |
| 10 | Sionna Therapeutics | 1.87 Bn | 1.87 Bn | - | -0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.60 |
| Dec 31, 2025 | -0.45 |
| Sep 30, 2025 | -0.46 |
| Jun 30, 2025 | -410.00 |
| Mar 31, 2025 | -0.62 |
| Dec 31, 2024 | -3.18 |
| Sep 30, 2024 | -5.67 |
| Jun 30, 2024 | -2,710.00 |
| Mar 31, 2024 | -3,840.00 |